scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1001591850 |
P356 | DOI | 10.1186/S12885-015-1039-X |
P932 | PMC publication ID | 4324426 |
P698 | PubMed publication ID | 25655565 |
P5875 | ResearchGate publication ID | 272079537 |
P2093 | author name string | Huasong Cai | |
Shi-Ting Feng | |||
Yanji Luo | |||
Zhi Dong | |||
Zi-Ping Li | |||
Ling Wu | |||
Tao Chan | |||
Keguo Zheng | |||
P2860 | cites work | Magnetic Resonance Imaging of cholangiocarcinoma | Q34533339 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications | Q35676335 | ||
Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. | Q37736159 | ||
Primovist, Eovist: what to expect? | Q38002724 | ||
Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. | Q38026533 | ||
Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention | Q40794590 | ||
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine | Q43184817 | ||
Biliary MR imaging with Gd-EOB-DTPA and its clinical applications | Q43230364 | ||
MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. | Q44871221 | ||
Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation | Q45001131 | ||
Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI. | Q46435374 | ||
Intraductal mucosal-spreading mucin-producing peripheral cholangiocarcinoma of the liver | Q50189344 | ||
Hilar cholangiocarcinoma: MR correlation with surgical and histological findings | Q52847170 | ||
Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. | Q53130915 | ||
Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects. | Q53195262 | ||
Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. | Q53485824 | ||
Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. | Q53941633 | ||
Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation | Q72989307 | ||
MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation | Q73927764 | ||
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma | Q74558715 | ||
Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma | Q75233624 | ||
Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma | Q80965276 | ||
Diagnostic challenge: intraductal neoplasms of the pancreatobiliary system | Q87431283 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cholangiocarcinoma | Q124292 |
P304 | page(s) | 38 | |
P577 | publication date | 2015-02-06 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity | |
P478 | volume | 15 |
Q33621543 | Multimodality imaging of intrahepatic cholangiocarcinoma | cites work | P2860 |
Search more.